Ligand validation:2WYC

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WYC_GOL_A_1175	82%	88%	0.085	0.938	0.26	0.41	-	-	0	0	100%	1
2WYC_GOL_B_1548	49%	75%	0.149	0.894	0.35	0.61	-	-	0	0	100%	1
2WYC_GOL_B_1549	47%	91%	0.134	0.874	0.37	0.22	-	-	1	0	100%	1
2WYC_GOL_A_1172	47%	90%	0.117	0.855	0.42	0.19	-	-	2	0	100%	1
2WYC_GOL_B_1547	37%	89%	0.152	0.85	0.41	0.24	-	-	0	0	100%	1
2WYC_GOL_A_1171	34%	86%	0.162	0.844	0.33	0.38	-	-	0	0	100%	1
2WYC_GOL_A_1174	31%	86%	0.159	0.827	0.44	0.28	-	-	0	0	100%	1
2WYC_GOL_A_1170	31%	80%	0.205	0.874	0.39	0.44	-	-	0	0	100%	1
2WYC_GOL_A_1173	29%	87%	0.178	0.834	0.31	0.39	-	-	0	0	100%	1
4M1J_GOL_A_202	85%	90%	0.081	0.944	0.26	0.34	-	-	0	0	100%	1
4WKV_GOL_A_202	83%	87%	0.102	0.962	0.31	0.38	-	-	0	0	100%	1
2WYD_GOL_A_1170	77%	84%	0.091	0.929	0.28	0.48	-	-	0	0	100%	1
4WKU_GOL_A_201	53%	92%	0.153	0.915	0.36	0.18	-	-	0	0	100%	1
4WKT_GOL_C_802	47%	87%	0.2	0.942	0.34	0.35	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.